Dr. Lusch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1617 Meadowlark Rd
Reading, PA 19610Phone+1 610-334-3433
Education & Training
- Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 1967 - 1968
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1965 - 1967
- Tower HealthResidency, Internal Medicine, 1962 - 1965
- Tower HealthInternship, Transitional Year, 1961 - 1962
- Lewis Katz School of Medicine at Temple UniversityClass of 1961
- Lafayette CollegeA.B., Magna Cum Laude, 1953 - 1957
Certifications & Licensure
- PA State Medical License 1962 - 2024
- HI State Medical License 2003 - 2020
- SC State Medical License 1988 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Recognition Best Doctors, 1996-2014
- Senate Award for service to patients of central Pennsylvania Pennsylvania Senate, 2008
- First "Healthcare Champion" Berks County VNA, 2008
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsAssessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Init...Margaret A. O'Grady, Elyse Slater, Elin R. Sigurdson, Neal J. Meropol, Alan Weinstein
Clinical Colorectal Cancer. 2011-06-01 - 26 citationsPhase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas.Richard Scher, R Kosierowski, Charles J. Lusch, Roland Alexander, Stephen Fox
Investigational New Drugs. 1995-12-01 - 3 citationsInhibitor treatment using unactivated prothrombin complex concentrates: the Pennsylvania experience--1978-1982.M. E. Eyster, Spero Ja, Catalano Pm, Frances M. Gill, C. J. Lusch
Progress in Clinical and Biological Research. 1984-01-01
Journal Articles
- Phase II Pilot Study of Daly Oral Etoposide and Hexamethylmelamine (Altretamine) In Small Cell Carcinoma of the LungLanger C.; Sprandio J.; Lusch, C.; Rousch R.; Kosierowski R.; Ozols R.; Fox S.; Reilly R.; Sarker C.R.; Galligher C., American Society of Clinical Oncology, 1/1/1999
- A Phase II Confirmatory Study of Antitumor Efficacy and Safety of Exemestane (EXE) As Third-Line Hormonal Treatment of Postmenopausal Patients (PTS) With Metastatic Br...Jones S.; Chang A.; Lusch C.; Belt R.; Arkhipov A.; Royer M.; Polli A.; di Salle E.; Miller L., Proceedings of the San Antonio Breast Cancer Conference, 1/1/1998
- Changing causes of death in Pennsylvania's Hemophiliacs 1976 – 1991: Impact of Liver Disease and Acquired Immunodeficiency SyndromeEyster, M.E.; Ragni, M.V.; Shapiro, S.; Kajani, M.K.; Barron, L.E.; Lusch, C.J.; DeGreen, H.P.; Cohen, A.R., Blood, 1/1/1992
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: